Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 28, 2016; 22(16): 4183-4190
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4183
Table 3 Association analysis between KIF1B variants and risk of hepatocellular carcinoma development n (%)
VariantsCrude OR (95%CI)P valueAdjusted OR1 (95%CI)P value1
rs3748578
GG1.001.00
AG0.74 (0.36-1.52)0.4110.71 (0.33-1.53)0.380
AA0.79 (0.57-1.09)0.1480.82 (0.58-1.62)0.260
Dominant model0.78 (0.57-1.07)0.1240.80 (0.57-1.13)0.209
Recessive model0.83 (0.41-1.67)0.5920.77 (0.36-1.65)0.507
Additive model0.82 (0.63-1.07)0.1370.83 (0.62-1.10)0.193
rs17401966
AA1.001.00
AG0.86 (0.62-1.20)0.3740.86 (0.62-1.20)0.379
GG1.10 (0.56-2.15)0.7781.12 (0.57-2.21)0.746
Dominant model0.89 (0.65-1.22)0.4670.91 (0.64-1.27)0.566
Recessive model1.18 (0.62-2.26)0.6201.06 (0.52-2.15)0.871
Additive model0.95 (0.73-1.23)0.6920.94 (0.71-1.25)0.685